# Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immune-checkpoint-inhibitors-in-egfr-mutated-nsclc-dusk-or-dawn/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Meng Qiao,Tao Jiang,Xinyu Liu,Shiqi Mao,Fei Zhou,Xuefei Li,Chao Zhao,Xiaoxia Chen,Chunxia Su,Shengxiang Ren,Caicun Zhou |
| Citations | 196 |
| DOI | 10.1016/j.jtho.2021.04.003 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3159640891 |
| PMID | 33915248 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Tao Jiang](https://scholariq.org/researchers/tao-jiang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.